Celsius (NASDAQ:CELH) Now Covered by The Goldman Sachs Group

Key Points

• The Goldman Sachs Group has initiated coverage on Celsius (NASDAQ:CELH) with a buy rating and a price target of $72.00, indicating a potential upside of 28.07% from its previous close.
• Analysts are generally optimistic, with 18 rating the stock as a buy and setting an average price target of $61.95.
• Celsius reported a notable increase in quarterly revenue, posting $739.30 million, which was significantly above analyst estimates.

The Goldman Sachs Group assumed coverage on shares of Celsius (NASDAQ:CELH - Get Free Report) in a report released on Thursday,Benzinga reports. The brokerage set a "buy" rating and a $72.00 price target on the stock. The Goldman Sachs Group's price objective would indicate a potential upside of 28.07% from the company's previous close.

Several other analysts have also weighed in on the stock. Maxim Group lifted their target price on shares of Celsius from $50.00 to $65.00 and gave the company a "buy" rating in a research report on Friday, August 8th. UBS Group boosted their price target on shares of Celsius from $64.00 to $73.00 and gave the company a "buy" rating in a research report on Tuesday, September 2nd. Jefferies Financial Group set a $72.00 price target on shares of Celsius and gave the company a "buy" rating in a research report on Wednesday, September 3rd. Stifel Nicolaus boosted their price target on shares of Celsius from $56.00 to $70.00 and gave the company a "buy" rating in a research report on Tuesday, September 2nd. Finally, Wells Fargo & Company boosted their price target on shares of Celsius from $44.00 to $45.00 and gave the company an "overweight" rating in a research report on Wednesday, June 4th. Eighteen analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $61.95.

Celsius Stock Performance

Shares of CELH opened at $56.22 on Thursday. The company has a market capitalization of $14.50 billion, a PE ratio of 151.95, a price-to-earnings-growth ratio of 1.27 and a beta of 1.34. Celsius has a one year low of $21.10 and a one year high of $63.50. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.11 and a quick ratio of 1.76. The company's fifty day moving average price is $51.90 and its 200 day moving average price is $41.61.

Celsius (NASDAQ:CELH - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.24. The company had revenue of $739.30 million for the quarter, compared to analyst estimates of $632.13 million. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The business's quarterly revenue was up 83.9% on a year-over-year basis. During the same period last year, the business posted $0.28 EPS. As a group, analysts expect that Celsius will post 0.89 earnings per share for the current year.

Insider Buying and Selling at Celsius

In related news, major shareholder William H. Milmoe sold 100,000 shares of the business's stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the completion of the sale, the insider directly owned 17,717,770 shares of the company's stock, valued at $841,594,075. The trade was a 0.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO Jarrod Langhans sold 5,000 shares of the business's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $60.00, for a total transaction of $300,000.00. Following the sale, the chief financial officer directly owned 104,227 shares of the company's stock, valued at approximately $6,253,620. This trade represents a 4.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 991,470 shares of company stock valued at $47,307,297 over the last 90 days. Company insiders own 2.55% of the company's stock.

Institutional Investors Weigh In On Celsius

Several large investors have recently bought and sold shares of CELH. Alliancebernstein L.P. boosted its holdings in shares of Celsius by 26.3% in the first quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company's stock valued at $642,769,000 after buying an additional 3,753,055 shares during the period. Scopus Asset Management L.P. acquired a new position in shares of Celsius in the second quarter valued at approximately $59,382,000. Ilex Capital Partners UK LLP acquired a new position in shares of Celsius in the second quarter valued at approximately $55,966,000. Holocene Advisors LP boosted its holdings in shares of Celsius by 130.6% in the second quarter. Holocene Advisors LP now owns 2,108,041 shares of the company's stock valued at $97,792,000 after buying an additional 1,193,707 shares during the period. Finally, AQR Capital Management LLC acquired a new position in shares of Celsius in the first quarter valued at approximately $39,412,000. Institutional investors own 60.95% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.